Product features

  • Purified complete microbial genome
  • Any sequence can be amplified
  • Concentration range: 12.500-20.000 copies/µl determined by qPCR
  • Can be used in any molecular testing platform
  • Non infectious
  • Lyophilized presentation
  • A resuspension vial is provided within the kit with Molecular Biology Grade Water

> Sequencing data available to assist in probe and primer design:
· Parainfluenza 1
· Human Parainfluenza 1
· Parainfluenza 2
· Parainfluenza 3
· Parainfluenza 4

Kit AMPLIRUN

PRODUCTS

AMPLIRUN® HUMAN PARAINFLUENZA 1 RNA CONTROL

RUO
Purified RNA of human parainfluenza 1 virus to be used to control techniques based in nucleic acids amplification.

Analytes: Parainfluenza

Reference MBC105-R
Concentración 12,500-20,000 copies/µl
Volume 50 µl

AMPLIRUN® PARAINFLUENZA 1 RNA CONTROL

CE0123 IVDR
Purified RNA of parainfluenza 1 virus to be used to control techniques based in nucleic acids amplification.

Analytes: Parainfluenza

Reference MBC037
Concentración 12,500-20,000 copies/µl
Volume 50 µl

AMPLIRUN® PARAINFLUENZA 2 RNA CONTROL

CE0123 IVDR
Purified RNA of parainfluenza 2 virus to be used to control techniques based in nucleic acids amplification.

Analytes: Parainfluenza

Reference MBC038
Concentración 12,500-20,000 copies/µl
Volume 50 µl

AMPLIRUN® PARAINFLUENZA 3 RNA CONTROL

CE0123 IVDR
Purified RNA of parainfluenza 3 virus to be used to control techniques based in nucleic acids amplification.

Analytes: Parainfluenza

Reference MBC039
Concentración 12,500-20,000 copies/µl
Volume 50 µl

AMPLIRUN® PARAINFLUENZA 4 A RNA CONTROL

CE0123 IVDR
Purified RNA of parainfluenza 4 A virus to be used to control techniques based in nucleic acids amplification.

Analytes: Parainfluenza

Reference MBC050
Concentración 12,500-20,000 copies/µl
Volume 50 µl

HOW IT WORKS

AMPLIRUN how to use vertical

MORE RESOURCES

Virus/Bacterias
RELATED VIRUSES/BACTERIA

Related germs and organisms categorized for this product line.

Flyers
FLYERS

Downloadable PDF materials, brochures, and technical documents.

Blog
BLOG

The latest insights, news, and research articles from our scientific team.

H. pylori stool antigen testing: when the test works, but the workflow no longer does
21 September 2026

H. pylori stool antigen testing: when the test works, but the workflow no longer does

Helicobacter pylori stool antigen testing is an established non-invasive approach for detecting active H. pylori infection. Validated monoclonal stool...

Polymicrobial Vaginal Infections: why third-party controls matter in molecular testing
10 August 2026

Polymicrobial Vaginal Infections: why third-party controls matter in molecular testing

Understanding the complexity of vaginal infectionsVaginal infections are among the most frequent reasons for gynecological consultation, but their dia...

Beyond detection: H. pylori testing in today’s laboratory workflow
31 July 2026

Beyond detection: H. pylori testing in today’s laboratory workflow

Helicobacter pylori remains a highly relevant target in gastrointestinal diagnostics. It is a familiar pathogen, but its clinical importance has not d...

Bibliography
BIBLIOGRAPHY

Scientific bibliography and references related to this product.

Broeders S, Garlant L, Fraiture MA, Vandermassen E, Suin V, Vanhomwegen J, et al. A new multiplex RT-qPCR method for the simultaneous detection and discrimination of Zika and chikungunya viruses. International Journal of Infectious Diseases. 2020 Mar 1;92
Jeong E, Kang M, Yun SA, Kim TY, Huh HJ. Evaluation of the STANDARD M10 Flu/RSV/SARS-CoV-2 Fast assay for the detection of influenza A/B viruses, respiratory syncytial virus, and SARS-CoV-2 in nasopharyngeal swab specimens. Microbiol Spectr. 2026 Mar 3;14
Korsun N, Angelova S, Tzotcheva I, Georgieva I, Lazova S, Parina S, et al. Prevalence and genetic characterisation of respiratory syncytial viruses circulating in Bulgaria during the 2014/15 and 2015/16 winter seasons. Pathogens and Global Health. 2017 Oc
Korsun N, Trifonova I, Madzharova I, Alexiev I, Uzunova I, Ivanov I, et al. Resurgence of respiratory syncytial virus with dominance of RSV-B during the 2022–2023 season. Frontiers in Microbiology [Internet]. 2024 Apr 2;15.
Steensels D, Delforge ML, Lagrou K, Beuselinck K, Montesinos I. Development of a customized TaqMan® Array Card for simultaneous detection of 32 respiratory pathogens. Adv Tech Clin Microbiol. 2017;1(3):19.